FDA Clears First Autonomous Telemedicine Robot for Hospitals

  FDA Clears First Autonomous Telemedicine Robot for Hospitals

  RP-VITA™, by iRobot and InTouch Health, enables doctors to provide patient
         care from anywhere in the world via a telemedicine solution

Business Wire

BEDFORD, Mass. -- January 24, 2013

iRobot Corp. (NASDAQ: IRBT), a leader in delivering robotic solutions,
announced that the RP-VITA Remote Presence Robot has received 510(k) clearance
by the U.S. Food and Drug Administration (FDA) for use in hospitals. RP-VITA
is the first autonomous navigation remote presence robot to receive FDA
clearance.

Using RP-VITA, a physician communicates with his patient remotely. (Photo:
Business Wire)

Using RP-VITA, a physician communicates with his patient remotely. (Photo:
Business Wire)

RP-VITA is a joint effort between two industry leaders, iRobot and InTouch
Health. The robot combines the latest in autonomous navigation and mobility
technologies developed by iRobot with state-of-the-art telemedicine and
electronic health record integration developed by InTouch Health. RP-VITA
allows remote doctor-to-patient consults, ensuring that the physician is in
the right place at the right time and has access to the necessary clinical
information to take immediate action. The robot has unprecedented ease of use.
It maps its own environment and uses an array of sophisticated sensors to
autonomously move about a busy space without interfering with people or other
objects. Using an intuitive iPad® interface, a doctor can visit a patient, and
communicate with hospital staff and patients with a single click, regardless
of their location.

The FDA clearance specifies that RP-VITA can be used for active patient
monitoring in pre-operative, peri-operative and post-surgical settings,
including cardiovascular, neurological, prenatal, psychological and critical
care assessments and examinations.

RP-VITA is being sold into the healthcare market by InTouch Health as its new
flagship remote presence device. iRobot will continue to explore adjacent
market opportunities for robots like RP-VITA and the iRobot Ava™ mobile
robotics platform.

“FDA clearance of a robot that can move safely and independently through a
fast-paced, chaotic and demanding hospital environment is a significant
technological milestone for the robotics and healthcare industries,” said
Colin Angle, chairman and CEO of iRobot. “There are very few environments as
difficult to maneuver as that of a busy ICU or emergency department. Having
crossed this technology threshold, the potential for self-navigating robots in
other markets, and for new applications, is virtually limitless.”

“Remote presence solutions have proven their worth in the medical arena for
quite some time,” said Yulun Wang, chairman and CEO of InTouch Health.
“RP-VITA has undergone stringent testing, and we are confident that the
robot’s ease of use and unique set of capabilities will enable new clinical
applications and uses.”

About iRobot Corp.
iRobot designs and builds robots that make a difference. The company’s home
robots help people find smarter ways to clean, and its defense & security
robots protect those in harm’s way. iRobot’s consumer and military robots
feature iRobot Aware® robot intelligence systems, proprietary technology
incorporating advanced concepts in navigation, mobility, manipulation and
artificial intelligence. For more information about iRobot, please visit
www.irobot.com.

For iRobot Investors
Certain statements made in this press release that are not based on historical
information are forward-looking statements which are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act of 1995.
This press release contains express or implied forward-looking statements
relating to, among other things, iRobot Corporation’s expectations concerning
delivery of technology for robots in hospitals. These statements are neither
promises nor guarantees, but are subject to a variety of risks and
uncertainties, many of which are beyond our control, which could cause actual
results to differ materially from those contemplated in these forward-looking
statements. Existing and prospective investors are cautioned not to place
undue reliance on these forward-looking statements, which speak only as of the
date hereof. iRobot Corporation undertakes no obligation to update or revise
the information contained in this press release, whether as a result of new
information, future events or circumstances or otherwise. For additional
disclosure regarding these and other risks faced by iRobot Corporation, see
the disclosure contained in our public filings with the Securities and
Exchange Commission including, without limitation, our most recent Annual
Report on Form 10-K.

About InTouch Health
InTouch Health is the leader in providing telemedicine solutions for
high-acuity applications where doctors are required to take immediate clinical
action. Its InTouch® Telemedicine System is the industry’s only fully
integrated end-to-end solution encompassing clinical data management, medical
imaging, 24/7 technical support, clinical consulting services and the
SureConnect® cloud-based infrastructure. By removing time and distance
barriers, the InTouch Telemedicine System effectively enables physicians to
perform real-time consults with hospital patients through a host of
purpose-built telemedicine devices. Deployed on six continents, over 10% of
all U.S. hospitals – including 13 of the nation’s top neuroscience centers of
excellence – use the InTouch Telemedicine System.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130124005134/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50540976&lang=en

Contact:

iRobot Corp.
Elise Caffrey, 781-430-3003
Investor Relations
ecaffrey@irobot.com
or
Charlie Vaida, 781-430-3182
Media Relations
cvaida@irobot.com
or
InTouch Health
Roselie Wright, 805-562-8686
Marketing Communications
rwright@intouchhealth.com